X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5234) 5234
Newsletter (270) 270
Newspaper Article (150) 150
Book Chapter (46) 46
Magazine Article (24) 24
Publication (12) 12
Dissertation (7) 7
Conference Proceeding (5) 5
Transcript (3) 3
Book / eBook (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rivaroxaban (4791) 4791
humans (3104) 3104
science & technology (3040) 3040
life sciences & biomedicine (2977) 2977
anticoagulants (1703) 1703
dabigatran (1627) 1627
apixaban (1436) 1436
male (1376) 1376
atrial fibrillation (1375) 1375
female (1323) 1323
anticoagulants - therapeutic use (1320) 1320
cardiovascular system & cardiology (1213) 1213
aged (1112) 1112
administration, oral (1071) 1071
middle aged (887) 887
warfarin (864) 864
anticoagulants - administration & dosage (848) 848
anticoagulants - adverse effects (847) 847
rivaroxaban - therapeutic use (817) 817
thromboembolism (816) 816
stroke (803) 803
hematology (782) 782
atrial fibrillation - drug therapy (775) 775
treatment outcome (715) 715
peripheral vascular disease (693) 693
morpholines - therapeutic use (691) 691
thiophenes - therapeutic use (686) 686
cardiac & cardiovascular systems (679) 679
stroke - prevention & control (650) 650
research (610) 610
hemorrhage - chemically induced (601) 601
risk factors (596) 596
rivaroxaban - administration & dosage (565) 565
pyridones - therapeutic use (562) 562
pyrazoles - therapeutic use (560) 560
care and treatment (554) 554
atrial fibrillation - complications (535) 535
rivaroxaban - adverse effects (531) 531
pharmacology & pharmacy (527) 527
factor xa inhibitors - therapeutic use (517) 517
thrombosis (510) 510
aged, 80 and over (503) 503
general & internal medicine (496) 496
warfarin - therapeutic use (473) 473
venous thromboembolism (469) 469
medicine, general & internal (466) 466
drug therapy (462) 462
abridged index medicus (459) 459
analysis (457) 457
adult (446) 446
factor xa inhibitors (436) 436
medical research (430) 430
beta-alanine - analogs & derivatives (429) 429
morpholines - administration & dosage (415) 415
thiophenes - administration & dosage (415) 415
prevention (409) 409
bleeding (406) 406
patients (406) 406
medicine, experimental (404) 404
morpholines - adverse effects (399) 399
thiophenes - adverse effects (398) 398
anticoagulation (363) 363
benzimidazoles - therapeutic use (359) 359
factor xa inhibitors - administration & dosage (358) 358
edoxaban (357) 357
cardiac arrhythmia (354) 354
factor xa inhibitors - adverse effects (354) 354
pyridones - administration & dosage (354) 354
pyrazoles - administration & dosage (353) 353
stroke - etiology (346) 346
venous thromboembolism - prevention & control (340) 340
retrospective studies (334) 334
thrombin (331) 331
dosage and administration (320) 320
medicine & public health (314) 314
venous thromboembolism - drug therapy (306) 306
dabigatran - therapeutic use (303) 303
pyridones - adverse effects (303) 303
pyrazoles - adverse effects (302) 302
blood coagulation - drug effects (283) 283
cardiology (283) 283
warfarin - adverse effects (282) 282
anticoagulants - pharmacology (279) 279
pulmonary embolism (277) 277
aspirin (274) 274
beta-alanine - therapeutic use (273) 273
hemorrhage (270) 270
vitamin k - antagonists & inhibitors (269) 269
clinical trials (267) 267
surgery (260) 260
physical fitness (246) 246
cardiovascular diseases (244) 244
pyridines - therapeutic use (239) 239
health aspects (236) 236
dabigatran - administration & dosage (230) 230
warfarin - administration & dosage (230) 230
usage (229) 229
dabigatran - adverse effects (213) 213
direct oral anticoagulants (212) 212
internal medicine (211) 211
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5222) 5222
German (179) 179
French (120) 120
Russian (102) 102
Spanish (94) 94
Japanese (47) 47
Czech (42) 42
Italian (26) 26
Portuguese (25) 25
Chinese (22) 22
Korean (17) 17
Hungarian (15) 15
Polish (14) 14
Turkish (11) 11
Swedish (8) 8
Norwegian (6) 6
Slovenian (5) 5
Dutch (4) 4
Finnish (3) 3
Slovak (3) 3
Danish (2) 2
Croatian (1) 1
Estonian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 03/2017, Volume 376, Issue 13, pp. 1211 - 1222
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Ryden, Lars and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and VOGEL, DANIEL and HRABAR, ADRIAN and CUNEO, CARLOS and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and CARDONA, MARCELO and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and ABRANTES, JOSE ANTONIO and MANENTI, EULER and MAIA, LILIA and HERNANDES, MAURO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and ABIB JR, EDUARDO and LEAES, PAULO and BOTELHO, ROBERTO and BRAILE, MARIA and IZUKAWA, NILO and TANAJURA, LUIZ FERNANDO and SERRANO JUNIOR, CARLOS VICENTE and NASI, LUIZ ANTONIO and TYTUS, RICHARD and PANDEY, SHEKHAR and LONN, EVA and CHA, JAMES and BABAPULLE, MOHAN and LAMY, ANDRE and KIAII, BOB and BHARGAVA, RAKESH and MEHTA, PRAVINSAGAR and HILL, LAURIE and FELL, DAVID and LAM, ANDY and AL-QOOFI, FAISAL and PETRELLA, ROBERT and GLANZ, ANTHONY and NOISEUX, NICOLAS and MERALI, FATIMA and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet (British edition), ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Evidence-based medicine | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2018, Volume 379, Issue 12, pp. 1118 - 1127
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2019, Volume 380, Issue 8, pp. 720 - 728
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke
Journal Article